Trinity Life Sciences Partners with Ontada to Enhance Real-World Oncology Data Analytics for Drug Development
核心洞察
Trinity Life Sciences (搜索) has formed a strategic collaboration with Ontada (搜索), a McKesson business, to provide life sciences companies with real-time oncology insights for pre- and post-launch decision making.
The partnership combines Trinity's commercial analytics expertise with Ontada (搜索)'s iKnowMed electronic health record system, which contains data from over 2.4 million patient records across 80+ tumor types.
The collaboration aims to accelerate commercial decision-making in community oncology through AI-enhanced analytics and deeper patient journey insights.
Trinity Life Sciences (搜索), a leader in advisory, insights and analytics for the life sciences industries, has announced a strategic collaboration with Ontada (搜索), a McKesson business specializing in community oncology real-world data, clinical education and point-of-care technologies. The partnership aims to provide life sciences companies with real-time, actionable intelligence and critical insights to drive strategic decisions both pre- and post-product launch.
Combining Analytics Expertise with Comprehensive Oncology Data
The alliance harnesses Trinity's innovative commercial analytics methods and expertise with Ontada (搜索)'s iKnowMed, their proprietary electronic health record (EHR) system containing unique, deep and multi-dimensional oncology data. This combination enables the rapid uncovering of novel commercial insights that can be leveraged to drive smarter decisions and better outcomes, ultimately transforming how life sciences companies make commercial decisions.
Through deep understanding of community oncology patients and providers, the collaborative solutions provide more powerful patient journeys and provider segmentation, allow for increased speed and accuracy in forecasting, and drive enhanced customer engagement and targeting.
Addressing Community Oncology Challenges
"Understanding community oncology presents a particular challenge for commercial teams as they work to develop strategies and deploy resources to maximize adoption of life-saving therapies," said Leslie Orne, president and CEO of Trinity Life Sciences (搜索). "Ontada (搜索)'s data, coupled with Trinity's analytical services, allows the extraction of deeper, more actionable insights and powers more impactful commercial decision-making that will help to optimize patient outcomes."
Trinity's oncology expertise spans areas including forecasting, real-world analytics and primary market research (PMR), enabling distinctive, AI-enhanced approaches that provide greater insight into key business questions to assess potential outcomes. The company offers innovative solutions built for life sciences' unique needs, scaling transformational AI and tech-enabled programs across functions with a focus on customer engagement, launch, medical affairs and GenAI.
Accelerating Insights for Cancer Care
"The need for rapid insights in cancer care has never been greater. Ontada (搜索)'s collaboration with Trinity demonstrates our commitment to delivering faster answers to critical questions," said Christine Davis, president of Ontada. "By connecting Trinity's robust analytics with Ontada's nuanced and unique data sets, we can provide deeper, more actionable insights for our life science partners. Speed is crucial not only to our life science partners but also for cancer patients, who can benefit greatly from a better understanding of precision therapies."
Comprehensive Real-World Data Platform
Ontada (搜索)'s real-world data provides comprehensive insights throughout the patient journey and offers a unique view of community cancer care. The platform represents data from more than 2.4 million patient records across over 80 tumor types from The US Oncology Network (搜索) and Onmark (搜索) practices. Ontada's iKnowMed is an award-winning EHR used by more than 2,400 oncology community-based providers across the United States, dedicated to advancing local cancer care and better patient outcomes.